Published: 27 Sep 2024(Updated: 27 Sep 2024)
33 min
33 min read
Jihen Melki, Thierry-Borel N'dri Kouadio, Mireille Nowakowski, Zara Razafiarimanga, Man-Koumba Soumahoro, Stephane Peltres, Ronan Jambou

Production and evaluation of a new set of recombinant antigens for the serological diagnosis of human cysticercosis

Researchers from the Department of Parasitology-Mycology at Institut Pasteur de Côte d'Ivoire are exploring new solutions for diagnosing human cysticercosis in remote areas. Their study tested a set of recombinant antigens for use in ELISA assays as a low-cost alternative to neuroimaging. While some challenges remain in optimizing sensitivity, the results show great promise, particularly in regions with limited medical resources. These antigens could provide a crucial screening tool for detecting neurocysticercosis, especially in patients with epilepsy, helping those in remote areas access better diagnosis and care.

We care about your privacy

We use cookies to improve user experience. We analyse our traffic, we personalise content and ads on our website, and we provide social media features. Certain cookies are necessary for our website to work properly and to enable you to use its features. With your consent, we also use analytics cookies to improve our website and marketing cookies to display advertisements and content on our website. 
Cookie settings